These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5335 related items for PubMed ID: 3856042

  • 21. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M.
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [Abstract] [Full Text] [Related]

  • 22. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
    Rak JW, Hegmann EJ, Lu C, Kerbel RS.
    J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
    [Abstract] [Full Text] [Related]

  • 23. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 24. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
    Erhard H, Rietveld FJ, van Altena MC, Bröcker EB, Ruiter DJ, de Waal RM.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S19-26. PubMed ID: 9578413
    [Abstract] [Full Text] [Related]

  • 25. Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
    Utikal J, Udart M, Leiter U, Peter RU, Krähn G.
    Int J Oncol; 2005 Mar; 26(3):597-605. PubMed ID: 15703813
    [Abstract] [Full Text] [Related]

  • 26. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
    Mortarini R, Borri A, Tragni G, Bersani I, Vegetti C, Bajetta E, Pilotti S, Cerundolo V, Anichini A.
    Cancer Res; 2000 Jul 01; 60(13):3559-68. PubMed ID: 10910069
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
    Ikoma N, Yamazaki H, Abe Y, Oida Y, Ohnishi Y, Suemizu H, Matsumoto H, Matsuyama T, Ohta Y, Ozawa A, Ueyama Y, Nakamura M.
    Oncol Rep; 2005 Sep 01; 14(3):633-7. PubMed ID: 16077966
    [Abstract] [Full Text] [Related]

  • 35. Clonal drift and role of chromosome dosage in human melanoma metastatic cell lines: a statistical analysis.
    Bailly M, Doré JF.
    Anticancer Res; 1992 Sep 01; 12(4):1163-72. PubMed ID: 1503405
    [Abstract] [Full Text] [Related]

  • 36. Monoclonal antibodies against human malignant melanoma.
    Sorg C, Brüggen J, Suter L, Bröcker EB.
    Bull Cancer; 1983 Sep 01; 70(2):113-7. PubMed ID: 6871486
    [Abstract] [Full Text] [Related]

  • 37. Skin equivalent: an attractive model to evaluate early melanoma metastasis.
    Dekker SK, van Doorn R, Kempenaar J, Gruis NA, Vermeer BJ, Ponec M.
    Melanoma Res; 2000 Apr 01; 10(2):127-40. PubMed ID: 10803713
    [Abstract] [Full Text] [Related]

  • 38. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.
    J Clin Oncol; 2005 Nov 01; 23(31):8048-56. PubMed ID: 16258103
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 267.